Pediatric primary cutaneous anaplastic large cell lymphoma treated with brachytherapy

Danny W. Linggonegoro; Lindsay McCormack; Pierre Olivier Grenier; Lynda M. Vrooman; Phillip M. Devlin; Jennifer T. Huang

doi:10.1111/pde.14585

Pediatric primary cutaneous anaplastic large cell lymphoma treated with brachytherapy

Danny W. Linggonegoro, Lindsay McCormack, Pierre Olivier Grenier, Lynda M. Vrooman, Phillip M. Devlin, Jennifer T. Huang

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Primary cutaneous anaplastic large cell lymphoma (PC-ALCL) is a CD30+ lymphoproliferative disorder that rarely occurs in children. Although there are currently no consensus guidelines for the treatment of cutaneous lymphoma in the pediatric population, the isolated form of PC-ALCL is typically managed by surgical excision or external beam radiation therapy. We report the case of a 6-year-old girl with primary cutaneous anaplastic large cell lymphoma that was treated with brachytherapy with no recurrence after 21 months of follow-up, suggesting that brachytherapy may be considered as a treatment for pediatric cutaneous large cell anaplastic lymphoma.

Original language	English
Pages (from-to)	712-713
Number of pages	2
Journal	Pediatric Dermatology
Volume	38
Issue number	3
DOIs	https://doi.org/10.1111/pde.14585
State	Published - May 1 2021
Externally published	Yes

Keywords

brachytherapy
pediatric
primary cutaneous anaplastic large cell lymphoma

Access to Document

10.1111/pde.14585

Cite this

@article{850901d79ee1437e9ebae25c33dbf0c7,

title = "Pediatric primary cutaneous anaplastic large cell lymphoma treated with brachytherapy",

abstract = "Primary cutaneous anaplastic large cell lymphoma (PC-ALCL) is a CD30+ lymphoproliferative disorder that rarely occurs in children. Although there are currently no consensus guidelines for the treatment of cutaneous lymphoma in the pediatric population, the isolated form of PC-ALCL is typically managed by surgical excision or external beam radiation therapy. We report the case of a 6-year-old girl with primary cutaneous anaplastic large cell lymphoma that was treated with brachytherapy with no recurrence after 21 months of follow-up, suggesting that brachytherapy may be considered as a treatment for pediatric cutaneous large cell anaplastic lymphoma.",

keywords = "brachytherapy, pediatric, primary cutaneous anaplastic large cell lymphoma",

author = "Linggonegoro, {Danny W.} and Lindsay McCormack and Grenier, {Pierre Olivier} and Vrooman, {Lynda M.} and Devlin, {Phillip M.} and Huang, {Jennifer T.}",

note = "Publisher Copyright: {\textcopyright} 2021 Wiley Periodicals LLC.",

year = "2021",

month = may,

day = "1",

doi = "10.1111/pde.14585",

language = "English",

volume = "38",

pages = "712--713",

journal = "Pediatric Dermatology",

issn = "0736-8046",

number = "3",

}

TY - JOUR

T1 - Pediatric primary cutaneous anaplastic large cell lymphoma treated with brachytherapy

AU - Linggonegoro, Danny W.

AU - McCormack, Lindsay

AU - Grenier, Pierre Olivier

AU - Vrooman, Lynda M.

AU - Devlin, Phillip M.

AU - Huang, Jennifer T.

PY - 2021/5/1

Y1 - 2021/5/1

N2 - Primary cutaneous anaplastic large cell lymphoma (PC-ALCL) is a CD30+ lymphoproliferative disorder that rarely occurs in children. Although there are currently no consensus guidelines for the treatment of cutaneous lymphoma in the pediatric population, the isolated form of PC-ALCL is typically managed by surgical excision or external beam radiation therapy. We report the case of a 6-year-old girl with primary cutaneous anaplastic large cell lymphoma that was treated with brachytherapy with no recurrence after 21 months of follow-up, suggesting that brachytherapy may be considered as a treatment for pediatric cutaneous large cell anaplastic lymphoma.

AB - Primary cutaneous anaplastic large cell lymphoma (PC-ALCL) is a CD30+ lymphoproliferative disorder that rarely occurs in children. Although there are currently no consensus guidelines for the treatment of cutaneous lymphoma in the pediatric population, the isolated form of PC-ALCL is typically managed by surgical excision or external beam radiation therapy. We report the case of a 6-year-old girl with primary cutaneous anaplastic large cell lymphoma that was treated with brachytherapy with no recurrence after 21 months of follow-up, suggesting that brachytherapy may be considered as a treatment for pediatric cutaneous large cell anaplastic lymphoma.

KW - brachytherapy

KW - pediatric

KW - primary cutaneous anaplastic large cell lymphoma

UR - http://www.scopus.com/inward/record.url?scp=85102763641&partnerID=8YFLogxK

U2 - 10.1111/pde.14585

DO - 10.1111/pde.14585

M3 - Article

C2 - 33742487

AN - SCOPUS:85102763641

SN - 0736-8046

VL - 38

SP - 712

EP - 713

JO - Pediatric Dermatology

JF - Pediatric Dermatology

IS - 3

ER -

Pediatric primary cutaneous anaplastic large cell lymphoma treated with brachytherapy

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this